Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors

Conclusion: Recognizing emphysema coexisting with NSCLC may help predict the therapeutic efficacy of ICIs in such patients.

Source: In Vivo - January 5, 2021 Category: Research Authors: TAKAYAMA, Y., NAKAMURA, T., FUKUSHIRO, Y., MISHIMA, S., MASUDA, K., SHODA, H. Tags: Clinical Studies Source Type: research